{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T17:28:11Z","timestamp":1785605291069,"version":"3.56.0"},"reference-count":53,"publisher":"European Respiratory Society (ERS)","issue":"5","license":[{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"funder":[{"name":"Emily's Entourage"},{"DOI":"10.13039\/501100000165","name":"Sick Kids Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000082","name":"Cystic Fibrosis Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000082","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2020,5,18]]},"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>Cystic fibrosis (CF) is a genetic disorder affecting multiple organs, including the pancreas, hepatobiliary system and reproductive organs; however, lung disease is responsible for the majority of morbidity and mortality. Management of CF involves CF transmembrane conductance regulator (CFTR) modulator agents including corrector drugs to augment cellular trafficking of mutant CFTR as well as potentiators that open defective CFTR channels. These therapies are poised to help most individuals with CF, with the notable exception of individuals with class I mutations where full-length CFTR protein is not produced. For these mutations, gene replacement has been suggested as a potential solution.<\/jats:p><jats:p>In this work, we used a helper-dependent adenoviral vector (HD-CFTR) to express CFTR in nasal epithelial cell cultures derived from CF subjects with class I CFTR mutations.<\/jats:p><jats:p>CFTR function was significantly restored in CF cells by HD-CFTR and reached healthy control functional levels as detected by Ussing chamber and membrane potential (FLIPR) assay. A dose\u2013response relationship was observed between the amount of vector used and subsequent functional outcomes; small amounts of HD-CFTR were sufficient to correct CFTR function. At higher doses, HD-CFTR did not increase CFTR function in healthy control cells above baseline values. This latter observation allowed us to use this vector to benchmark<jats:italic>in vitro<\/jats:italic>efficacy testing of CFTR-modulator drugs.<\/jats:p><jats:p>In summary, we demonstrate the potential for HD-CFTR to inform<jats:italic>in vitro<\/jats:italic>testing and to restore CFTR function to healthy control levels in airway cells with class I or CFTR nonsense mutations.<\/jats:p>","DOI":"10.1183\/13993003.00205-2020","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T19:51:42Z","timestamp":1590522702000},"page":"2000205","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["A helper-dependent adenoviral vector rescues CFTR to wild-type functional levels in cystic fibrosis epithelial cells harbouring class I mutations"],"prefix":"10.1183","volume":"56","author":[{"given":"Huibi","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onofrio","family":"Laselva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichang Peter","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarini","family":"Gunawardena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Avolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Bear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Gonska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo J.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,5,26]]},"reference":[{"key":"2024102101440327000_56.5.2000205.1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2475911"},{"key":"2024102101440327000_56.5.2000205.2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MCP.0000000000000208","article-title":"Country to country variation: what can be learnt from national cystic fibrosis registries","volume":"21","author":"Goss","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"2024102101440327000_56.5.2000205.3","doi-asserted-by":"crossref","first-page":"15010","DOI":"10.1038\/nrdp.2015.10","article-title":"Cystic fibrosis","volume":"1","author":"Ratjen","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2024102101440327000_56.5.2000205.4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0904709106"},{"key":"2024102101440327000_56.5.2000205.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201704-0717OC"},{"key":"2024102101440327000_56.5.2000205.6","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2016.52.4.2467205"},{"key":"2024102101440327000_56.5.2000205.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409547"},{"key":"2024102101440327000_56.5.2000205.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709847"},{"key":"2024102101440327000_56.5.2000205.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709846"},{"key":"2024102101440327000_56.5.2000205.10","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMe1811996","article-title":"Triple CFTR modulator therapy for cystic fibrosis","volume":"379","author":"Holguin","year":"2018","journal-title":"N Engl J Med"},{"key":"2024102101440327000_56.5.2000205.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1807119"},{"key":"2024102101440327000_56.5.2000205.12","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N Engl J Med"},{"key":"2024102101440327000_56.5.2000205.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"2024102101440327000_56.5.2000205.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32597-8"},{"key":"2024102101440327000_56.5.2000205.15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jcf.2019.12.001","article-title":"Functional rescue of c.3846G>A (W1282X) in patient-derived nasal cultures achieved by inhibition of nonsense mediated decay and protein modulators with complementary mechanisms of action","volume":"19","author":"Laselva","year":"2020","journal-title":"J Cyst Fibros"},{"key":"2024102101440327000_56.5.2000205.16","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1093\/hmg\/ddz139","article-title":"Advances in gene therapy for cystic fibrosis lung disease","volume":"28","author":"Yan","year":"2019","journal-title":"Hum Mol Genet"},{"key":"2024102101440327000_56.5.2000205.17","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-2600(15)00245-3","article-title":"Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial","volume":"3","author":"Alton","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2024102101440327000_56.5.2000205.18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.26.14695"},{"key":"2024102101440327000_56.5.2000205.19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/gt.2010.125","article-title":"Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression","volume":"18","author":"Cao","year":"2011","journal-title":"Gene Ther"},{"key":"2024102101440327000_56.5.2000205.20","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1038\/mtna.2013.55","article-title":"Efficient gene delivery to pig airway epithelia and submucosal glands using helper-dependent adenoviral vectors","volume":"2","author":"Cao","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"key":"2024102101440327000_56.5.2000205.21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF03402113","article-title":"Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector","volume":"6","author":"O'Neal","year":"2000","journal-title":"Mol Med"},{"key":"2024102101440327000_56.5.2000205.22","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-0016(03)00059-5"},{"key":"2024102101440327000_56.5.2000205.23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/hum.2017.201","article-title":"Transducing airway basal cells with a helper-dependent adenoviral vector for lung gene therapy","volume":"29","author":"Cao","year":"2018","journal-title":"Hum Gene Ther"},{"key":"2024102101440327000_56.5.2000205.24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0906850106"},{"key":"2024102101440327000_56.5.2000205.25","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.797"},{"key":"2024102101440327000_56.5.2000205.26","doi-asserted-by":"crossref","first-page":"15034","DOI":"10.1038\/mtm.2015.34","article-title":"Testing gene therapy vectors in human primary nasal epithelial cultures","volume":"2","author":"Cao","year":"2015","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2024102101440327000_56.5.2000205.27","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2017-0345OC"},{"key":"2024102101440327000_56.5.2000205.28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jcf.2018.03.013","article-title":"The CF Canada-Sick Kids Program in individual CF therapy: a resource for the advancement of personalized medicine in CF","volume":"18","author":"Eckford","year":"2019","journal-title":"J Cyst Fibros"},{"key":"2024102101440327000_56.5.2000205.29","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201607137"},{"key":"2024102101440327000_56.5.2000205.30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41525-017-0015-6","article-title":"Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia","volume":"2","author":"Ahmadi","year":"2017","journal-title":"NPJ Genom Med"},{"key":"2024102101440327000_56.5.2000205.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2436478100"},{"key":"2024102101440327000_56.5.2000205.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2003.08.014"},{"key":"2024102101440327000_56.5.2000205.33","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-237-3_3"},{"key":"2024102101440327000_56.5.2000205.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07504-1"},{"key":"2024102101440327000_56.5.2000205.35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1513\/AnnalsATS.201708-668PS","article-title":"The U.S. Food and Drug Administration's experience with ivacaftor in cystic fibrosis. Establishing efficacy using in vitro data in lieu of a clinical trial","volume":"15","author":"Durmowicz","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2024102101440327000_56.5.2000205.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0393-7"},{"key":"2024102101440327000_56.5.2000205.37","doi-asserted-by":"publisher","DOI":"10.1124\/mol.119.117143"},{"key":"2024102101440327000_56.5.2000205.38","unstructured":"StemCell Technologies . PneumaCult; Serum- and Bovine Pituitary Extract (BPE)-Free Media for Airway Epithelial Cells. 2020. www.stemcell.com\/products\/brands\/pneumacult-airway-epithelial-culture.html Date last accessed: April 11, 2020."},{"key":"2024102101440327000_56.5.2000205.39","doi-asserted-by":"publisher","DOI":"10.2174\/156652307782151452"},{"key":"2024102101440327000_56.5.2000205.40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41565-018-0358-x","article-title":"Self-assembled peptide\u2013poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis","volume":"14","author":"Guan","year":"2019","journal-title":"Nat Nanotechnol"},{"key":"2024102101440327000_56.5.2000205.41","first-page":"GE01","article-title":"Non viral vectors in gene therapy \u2013 an overview","volume":"9","author":"Ramamoorthi","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"2024102101440327000_56.5.2000205.42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/17425247.2016.1214569","article-title":"Inhaled gene delivery: a formulation and delivery approach","volume":"14","author":"Gomes Dos Reis","year":"2017","journal-title":"Expert Opin Drug Deliv"},{"key":"2024102101440327000_56.5.2000205.43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/humc.2014.019","article-title":"Aerosol delivery of DNA\/liposomes to the lung for cystic fibrosis gene therapy","volume":"25","author":"Davies","year":"2014","journal-title":"Hum Gene Ther Clin Dev"},{"key":"2024102101440327000_56.5.2000205.44","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2001.0435"},{"key":"2024102101440327000_56.5.2000205.45","doi-asserted-by":"publisher","DOI":"10.2741\/e401"},{"key":"2024102101440327000_56.5.2000205.46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ppul.20199","article-title":"The CFTR gene and regulation of its expression","volume":"40","author":"McCarthy","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"2024102101440327000_56.5.2000205.47","doi-asserted-by":"crossref","first-page":"20653","DOI":"10.1016\/S0021-9258(20)80774-1","article-title":"Functional consequences of heterologous expression of the cystic fibrosis transmembrane conductance regulator in fibroblasts","volume":"268","author":"Stutts","year":"1993","journal-title":"J Biol Chem"},{"key":"2024102101440327000_56.5.2000205.48","doi-asserted-by":"crossref","first-page":"L333","DOI":"10.1152\/ajplung.2000.279.2.L333","article-title":"CFTR modulates lung secretory cell proliferation and differentiation","volume":"279","author":"Larson","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2024102101440327000_56.5.2000205.49","doi-asserted-by":"publisher","DOI":"10.1002\/dvdy.20912"},{"key":"2024102101440327000_56.5.2000205.50","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1994.5.6-717"},{"key":"2024102101440327000_56.5.2000205.51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad8278"},{"key":"2024102101440327000_56.5.2000205.52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jcf.2014.05.007","article-title":"CFTR functional measurements in human models for diagnosis, prognosis and personalized therapy: report on the pre-conference meeting to the 11th ECFS Basic Science Conference, Malta, 26\u201329 March 2014","volume":"13","author":"Beekman","year":"2014","journal-title":"J Cyst Fibros"},{"key":"2024102101440327000_56.5.2000205.53","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.stemcr.2015.02.005","article-title":"Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells","volume":"4","author":"Crane","year":"2015","journal-title":"Stem Cell Reports"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00205-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:34:14Z","timestamp":1740382454000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00205-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,26]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,11,12]]},"published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1183\/13993003.00205-2020"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00205-2020","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,26]]}}}